The Authors Reply
- PMID: 30596187
- PMCID: PMC6308827
- DOI: 10.1016/j.ekir.2018.10.011
The Authors Reply
References
-
- U.S. Food and Drug Administration. Drug approval package. Cyanokit (hydroxocobalamin for injection) 5 g for intravenous use. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/022041_cyanokit_.... Accessed October 10, 2018.
-
- Merck KGaA; Darmstadt: 2014. EMD Serono. CYANOKIT® Product Monograph.
-
- Borron S.W., Stonerook M., Reid F. Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs. Clin Toxicol (Phila) 2006;44:5–15. - PubMed
-
- Borron S.W., Baud F.J., Barriot P. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med. 2007;49:794–801. - PubMed
-
- Legrand M., Michel T., Daudon M. Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients. Intensive Care Med. 2016;42:1080–1081. - PubMed
LinkOut - more resources
Full Text Sources